NO316619B1 - Fat blend containing ß-sitosterol or ß-sitosterol and ß-sitostanol, a process for producing such a fat blend, using the same and a process for administering ß-sitosterol or ß-sitosterol and ß-sitostanol to lower serum tot - Google Patents
Fat blend containing ß-sitosterol or ß-sitosterol and ß-sitostanol, a process for producing such a fat blend, using the same and a process for administering ß-sitosterol or ß-sitosterol and ß-sitostanol to lower serum tot Download PDFInfo
- Publication number
- NO316619B1 NO316619B1 NO20004269A NO20004269A NO316619B1 NO 316619 B1 NO316619 B1 NO 316619B1 NO 20004269 A NO20004269 A NO 20004269A NO 20004269 A NO20004269 A NO 20004269A NO 316619 B1 NO316619 B1 NO 316619B1
- Authority
- NO
- Norway
- Prior art keywords
- sitosterol
- mixture
- oil
- fat
- sitostanol
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 169
- 229950005143 sitosterol Drugs 0.000 title claims description 143
- 238000000034 method Methods 0.000 title claims description 30
- 210000002966 serum Anatomy 0.000 title claims description 12
- 230000008569 process Effects 0.000 title claims description 5
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 title description 19
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 title description 15
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 title description 15
- 229940076810 beta sitosterol Drugs 0.000 title description 10
- LGJMUZUPVCAVPU-JFBKYFIKSA-N Sitostanol Natural products O[C@@H]1C[C@H]2[C@@](C)([C@@H]3[C@@H]([C@H]4[C@@](C)([C@@H]([C@@H](CC[C@H](C(C)C)CC)C)CC4)CC3)CC2)CC1 LGJMUZUPVCAVPU-JFBKYFIKSA-N 0.000 title description 3
- LGJMUZUPVCAVPU-HRJGVYIJSA-N stigmastanol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]2(C)CC1 LGJMUZUPVCAVPU-HRJGVYIJSA-N 0.000 title 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 67
- 239000003925 fat Substances 0.000 claims description 51
- 235000019197 fats Nutrition 0.000 claims description 51
- 239000003921 oil Substances 0.000 claims description 35
- 235000019198 oils Nutrition 0.000 claims description 35
- 239000007858 starting material Substances 0.000 claims description 33
- 235000013305 food Nutrition 0.000 claims description 30
- 235000014121 butter Nutrition 0.000 claims description 24
- 235000013310 margarine Nutrition 0.000 claims description 20
- 239000003264 margarine Substances 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 238000008214 LDL Cholesterol Methods 0.000 claims description 13
- 150000003839 salts Chemical class 0.000 claims description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- 241001465754 Metazoa Species 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 8
- 239000004094 surface-active agent Substances 0.000 claims description 8
- 235000013311 vegetables Nutrition 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 6
- 239000000194 fatty acid Substances 0.000 claims description 6
- 229930195729 fatty acid Natural products 0.000 claims description 6
- 235000015067 sauces Nutrition 0.000 claims description 6
- 235000005687 corn oil Nutrition 0.000 claims description 5
- 239000002285 corn oil Substances 0.000 claims description 5
- 150000004665 fatty acids Chemical class 0.000 claims description 5
- 235000008390 olive oil Nutrition 0.000 claims description 5
- 239000004006 olive oil Substances 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- -1 vitamins A and E Natural products 0.000 claims description 5
- 235000019486 Sunflower oil Nutrition 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 239000003995 emulsifying agent Substances 0.000 claims description 4
- 229920000136 polysorbate Polymers 0.000 claims description 4
- 229950008882 polysorbate Drugs 0.000 claims description 4
- 235000013599 spices Nutrition 0.000 claims description 4
- 239000002600 sunflower oil Substances 0.000 claims description 4
- 240000002791 Brassica napus Species 0.000 claims description 3
- 238000010411 cooking Methods 0.000 claims description 3
- 235000013365 dairy product Nutrition 0.000 claims description 3
- 239000008157 edible vegetable oil Substances 0.000 claims description 3
- 235000013373 food additive Nutrition 0.000 claims description 3
- 239000002778 food additive Substances 0.000 claims description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 3
- 239000011707 mineral Substances 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 235000012424 soybean oil Nutrition 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 235000019155 vitamin A Nutrition 0.000 claims description 3
- 239000011719 vitamin A Substances 0.000 claims description 3
- 235000019165 vitamin E Nutrition 0.000 claims description 3
- 239000011709 vitamin E Substances 0.000 claims description 3
- 235000012970 cakes Nutrition 0.000 claims description 2
- 235000019219 chocolate Nutrition 0.000 claims description 2
- 235000009508 confectionery Nutrition 0.000 claims description 2
- 235000015071 dressings Nutrition 0.000 claims description 2
- 235000013332 fish product Nutrition 0.000 claims description 2
- 235000012041 food component Nutrition 0.000 claims description 2
- 239000005417 food ingredient Substances 0.000 claims description 2
- 235000015243 ice cream Nutrition 0.000 claims description 2
- 235000014593 oils and fats Nutrition 0.000 claims description 2
- 230000036961 partial effect Effects 0.000 claims description 2
- 235000014594 pastries Nutrition 0.000 claims description 2
- 235000020991 processed meat Nutrition 0.000 claims description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims 2
- 235000013355 food flavoring agent Nutrition 0.000 claims 2
- 239000000787 lecithin Substances 0.000 claims 2
- 229940067606 lecithin Drugs 0.000 claims 2
- 235000010445 lecithin Nutrition 0.000 claims 2
- 230000002335 preservative effect Effects 0.000 claims 2
- 235000011293 Brassica napus Nutrition 0.000 claims 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 claims 1
- 235000011868 grain product Nutrition 0.000 claims 1
- 235000012000 cholesterol Nutrition 0.000 description 14
- 229930182558 Sterol Natural products 0.000 description 13
- 235000015927 pasta Nutrition 0.000 description 13
- 150000003432 sterols Chemical class 0.000 description 13
- 235000003702 sterols Nutrition 0.000 description 13
- 239000000047 product Substances 0.000 description 12
- 235000015500 sitosterol Nutrition 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 7
- 230000001906 cholesterol absorption Effects 0.000 description 7
- 239000008162 cooking oil Substances 0.000 description 7
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 5
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 5
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 5
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 5
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 5
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 239000004570 mortar (masonry) Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- LGJMUZUPVCAVPU-ANOYILKDSA-N (3s,8r,9s,10s,13r,14s,17r)-17-[(2r,5s)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-ol Chemical class C1CC2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@H](CC)C(C)C)[C@@]1(C)CC2 LGJMUZUPVCAVPU-ANOYILKDSA-N 0.000 description 4
- 229910000831 Steel Inorganic materials 0.000 description 4
- 235000012846 chilled/fresh pasta Nutrition 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 235000013550 pizza Nutrition 0.000 description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 4
- 229920000053 polysorbate 80 Polymers 0.000 description 4
- 229940083492 sitosterols Drugs 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000010959 steel Substances 0.000 description 4
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 3
- 235000006008 Brassica napus var napus Nutrition 0.000 description 3
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 3
- 244000188595 Brassica sinapistrum Species 0.000 description 3
- 244000098345 Triticum durum Species 0.000 description 3
- 235000007264 Triticum durum Nutrition 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 235000013351 cheese Nutrition 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000008268 mayonnaise Substances 0.000 description 3
- 235000010746 mayonnaise Nutrition 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 2
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 2
- 235000000431 campesterol Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000008344 egg yolk phospholipid Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 229940049964 oleate Drugs 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 229940068065 phytosterols Drugs 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 229940068968 polysorbate 80 Drugs 0.000 description 2
- 229940083466 soybean lecithin Drugs 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- LPZCCMIISIBREI-JXMPMKKESA-N (Z)-24-ethylidenelophenol Chemical compound C[C@@H]1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)CC/C(=C/C)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 LPZCCMIISIBREI-JXMPMKKESA-N 0.000 description 1
- ARYTXMNEANMLMU-UHFFFAOYSA-N 24alpha-methylcholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(C)C(C)C)C1(C)CC2 ARYTXMNEANMLMU-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 102000004286 Hydroxymethylglutaryl CoA Reductases Human genes 0.000 description 1
- 108090000895 Hydroxymethylglutaryl CoA Reductases Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000000853 LDL receptors Human genes 0.000 description 1
- 108010001831 LDL receptors Proteins 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 235000021068 Western diet Nutrition 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003529 anticholesteremic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036523 atherogenesis Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- ARYTXMNEANMLMU-ATEDBJNTSA-N campestanol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]2(C)CC1 ARYTXMNEANMLMU-ATEDBJNTSA-N 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 235000020974 cholesterol intake Nutrition 0.000 description 1
- 238000000975 co-precipitation Methods 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 230000006957 competitive inhibition Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000498 cooling water Substances 0.000 description 1
- 235000015142 cultured sour cream Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 235000015432 dried pasta Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003778 fat substitute Substances 0.000 description 1
- 235000013341 fat substitute Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000000576 food coloring agent Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 150000002634 lipophilic molecules Chemical class 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C15/00—Butter; Butter preparations; Making thereof
- A23C15/12—Butter preparations
- A23C15/126—Butter containing a minority of vegetable oils; Enrichment of butter with fatty acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/14—Organic oxygen compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C15/00—Butter; Butter preparations; Making thereof
- A23C15/12—Butter preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/003—Compositions other than spreads
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/346—Finished or semi-finished products in the form of powders, paste or liquids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/40—Meat products; Meat meal; Preparation or treatment thereof containing additives
- A23L13/42—Additives other than enzymes or microorganisms in meat products or meat meals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/109—Types of pasta, e.g. macaroni or noodles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G2200/00—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents
- A23G2200/08—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents containing cocoa fat if specifically mentioned or containing products of cocoa fat or containing other fats, e.g. fatty acid, fatty alcohol, their esters, lecithin, paraffins
Description
Oppfinnelse vedrører en fettblanding inneholdende P-sitosterol, eller P-sitosterol og p-sitostanol, som senker serumtotalkolesterol- og LDL-kolesterolnivåene, en fremgangsmåte for å produsere en slik fettblanding, andvendelse av samme, og en fremgangsmåte for tilføring av p-sitosterol, eller p-sitosterol og P-sitostanol, for å senke serumtotale kolesterol- og LDL-kolesterolnivåer, i matvareprodukter. The invention relates to a fat mixture containing P-sitosterol, or P-sitosterol and p-sitostanol, which lowers serum total cholesterol and LDL cholesterol levels, a method for producing such a fat mixture, the use thereof, and a method for supplying p-sitosterol, or p-sitosterol and p-sitostanol, to lower serum total cholesterol and LDL cholesterol levels, in food products.
Et høyt totalt serumkolesterolnivå, hypertensjon og røyking er hovedrisikofaktorene tilknyttet en hjertelidelse (1). Det finnes flere steroler med planteopphav som er forskjellige fra kolesterol kun ved sidekjedesubstituenter og ved graden av metning. De fleste av de høyere plantene produserer 24a-substituert steroler (24-metyl- og 24-etyl-steroler). Sitosteroler er blandinger av p-sitosterol (stigmasa-5-en-3p-ole) og visse mettede steroler, så som p-sitostanol, som inneholder ikke mindre enn 95% steroler, og umettede steroler ikke mindre enn 85%. Sitosteroler er i stor grad tilstede i planter, så som i hvete og rugspireoljer, kornolje, og er vanlig i frøoljer. Sitosteroler er antihyper-kolesterolemiske midler som inhibiterer absorpsjon av kolesterol i tarmen, og gjennom blodkarenes indre vegger (2). Sitosteroler spiller en rolle i behandlingen av atero-sklerose når de administreres i doser på 2 - 3 gram, tre ganger pr. dag. I den vestlige diett er det daglige opptaket av p-sitosterol, stigmasterol og kampesterol fra mat om lag 200 - 400 mg (3), som er om lag samme størrelsesorden som vårt daglige kolesterolopptak fra mat. A high total serum cholesterol level, hypertension and smoking are the main risk factors associated with a heart condition (1). There are several sterols of plant origin that differ from cholesterol only by side chain substituents and by the degree of saturation. Most of the higher plants produce 24α-substituted sterols (24-methyl- and 24-ethyl-sterols). Sitosterols are mixtures of p-sitosterol (stigmasa-5-en-3p-ole) and certain saturated sterols, such as p-sitostanol, which contain not less than 95% sterols, and unsaturated sterols not less than 85%. Sitosterols are largely present in plants, such as in wheat and rye germ oils, corn oil, and are common in seed oils. Sitosterols are antihyper-cholesterolemic agents that inhibit the absorption of cholesterol in the intestine, and through the inner walls of the blood vessels (2). Sitosterols play a role in the treatment of atherosclerosis when administered in doses of 2 - 3 grams, three times a day. day. In the Western diet, the daily intake of p-sitosterol, stigmasterol and campesterol from food is about 200 - 400 mg (3), which is about the same order of magnitude as our daily cholesterol intake from food.
Ved begynnelsen av 1950-årene, var det anerkjent at som et resultat av tilførselen av P-sitosterol i foret til kolesterolforede kyllinger og kaniner, ble kolesterolnivåene senket i begge testdyrene, og videre forhindret denne tilførsel av p-sitosterol aterogenese i kaniner (4). Bruken av sitosterol og soyabønnesteroler for å senke kolesterolnivåer ble studert intenst i 1950-årene og 1960-årene (5), og preparater som fremkom av dette senket virkelig kolesterolnivåene med om lag 10% (6). Man oppdaget så at p-sitosterolaktiviteten var basert på inhibisjonen av absorpsjon av kolesterol, og at steroler med planteopphav ble selv dårlig absorbert (7). Mekanismen som hemmer absorpsjon av kolesterol var antatt å være basert på krystallisering og medutfelling av kolesterol og p-sitosterol. Mattson et al. (8) viste at et gram med p-sitosterol reduserer absorpsjonen av kolesterol fra mat som inneholder 500 mg av kolesterol, med 42%. Reduksjonen i plasmakolesterol kan være på grunn av den økte aktiviteten av LDL-reseptorer. By the early 1950s, it was recognized that as a result of the addition of p-sitosterol in the feed of cholesterol-fed chickens and rabbits, cholesterol levels were lowered in both test animals, and furthermore, this addition of p-sitosterol prevented atherogenesis in rabbits (4) . The use of sitosterol and soybean sterols to lower cholesterol levels was studied intensively in the 1950s and 1960s (5), and the resulting preparations actually lowered cholesterol levels by about 10% (6). It was then discovered that p-sitosterol activity was based on the inhibition of absorption of cholesterol, and that sterols of plant origin were themselves poorly absorbed (7). The mechanism that inhibits the absorption of cholesterol was thought to be based on the crystallization and co-precipitation of cholesterol and p-sitosterol. Mattson et al. (8) showed that one gram of p-sitosterol reduces the absorption of cholesterol from food containing 500 mg of cholesterol by 42%. The reduction in plasma cholesterol may be due to the increased activity of LDL receptors.
p-sitosterol er en liptofil sammensetning. Ved berøring med tarmveggenes lipid-membraner, vil ikke p-sitosterol absorberes på grunn av dets dårlige vannløselighet, eller kun en liten del av det vil bli absorbert. Når det administreres oralt, vil kun mindre p-sitosterol is a lipophilic compound. In contact with the lipid membranes of the intestinal walls, p-sitosterol will not be absorbed due to its poor water solubility, or only a small part of it will be absorbed. When administered orally, only less will
enn 5% bli absorbert (9). P-sitosterolaktiviteten er basert på kompetetiv inhibisjon av kolesterolabsorpsjon i innvollene (10). p-sitosterol interfererer med kolesterolresorpsjon og re-resorpsjon i tynntarmen (11). Man antar at dette skyldes likheten mellom de kjemiske strukturene i kolesterol og P-sitosterol (12). Flere studier som ble utført under ulike forhold har vist at pytosteroler senker LDL-kolesterolnivåer. Det er videre anerkjent at serumpytosteroler korrelerer med HDL-nivåer. p-sitosterol reduserer syntesen av kolesterol i leveren ved å affisere genfremstillingen av HMG-CoA reduktase (13). Richter W. et al (14) har vist at P-sitosterol senker det totale serum-kolesterolnivået med 10 -15%, og LDL-kolesterolnivået med 19%, ved å inhibere absorpsjon av kolesterol i tarmen. Ved en studie ble ni voksne pasienter gitt 500 mg kolesterol i 5 dager, så vel som et gram p-sitosterol, eller to gram med p-sitosterol oleat. Kolesterolabsorpsjonen ble senket med 42% når det ble administrert p-sitosterol, og med 33% når det ble administrert p-sitosteryl oleat (15). Uchita et al. (16) har funnet at sitosterol hemmer kolesterolabsorpsjon i hunn-rotter, og senker kolesterolbalansen i plasma og lever. Vahouny et al. (17) har funnet at sitosterol inhiberer kolesterolabsorpsjon i rotter med 54%. than 5% be absorbed (9). P-sitosterol activity is based on competitive inhibition of cholesterol absorption in the intestines (10). p-sitosterol interferes with cholesterol absorption and re-absorption in the small intestine (11). It is assumed that this is due to the similarity between the chemical structures of cholesterol and P-sitosterol (12). Several studies conducted under different conditions have shown that phytosterols lower LDL cholesterol levels. It is further recognized that serum phytosterols correlate with HDL levels. p-sitosterol reduces the synthesis of cholesterol in the liver by affecting the gene production of HMG-CoA reductase (13). Richter W. et al (14) have shown that P-sitosterol lowers the total serum cholesterol level by 10 -15%, and the LDL cholesterol level by 19%, by inhibiting the absorption of cholesterol in the intestine. In one study, nine adult patients were given 500 mg of cholesterol for 5 days, as well as one gram of p-sitosterol, or two grams of p-sitosterol oleate. Cholesterol absorption was lowered by 42% when p-sitosterol was administered, and by 33% when p-sitosteryl oleate was administered (15). Uchita et al. (16) have found that sitosterol inhibits cholesterol absorption in female rats, and lowers the cholesterol balance in plasma and liver. Vahouny et al. (17) have found that sitosterol inhibits cholesterol absorption in rats by 54%.
Finsk patentsøknad nr. 964951 gjør rede for et middel for å senke kolesterolnivået i serum, og bruken av dette. Denne søknaden angår bruken av en ester av p-sitostanol med en fettsyre eller en blanding av estere med p-sitostanol med en fettsyre som en fettkomponent eller som et fettsubstitutt i matprodukter, bruken av dette som sådan, supplering av dietten, og selve sammensetningen. Finnish patent application No. 964951 discloses an agent for lowering serum cholesterol levels and its use. This application concerns the use of an ester of p-sitostanol with a fatty acid or a mixture of esters with p-sitostanol with a fatty acid as a fat component or as a fat substitute in food products, its use as such, supplementation of the diet, and the composition itself.
Finsk patentsøknad nr. 98 730 redegjør for en fremgangsmåte for å produsere en substans for å senke høye serumkolesterolnivåer. I fremgangsmåten benyttes p-sitostanol, laget av p-sitosterol ved å hydrere i ett organisk løsningsmiddel i nærvær av palladium på karbon som en katalysator, og en planteolje for å produsere et ester av p-sitostanol med en fettsyre, eller en blanding av slike estere, ved å benytte trans-forestringsteknikken i nærvær av en natriumetylatkatalysator. Finnish Patent Application No. 98,730 discloses a method for producing a substance for lowering high serum cholesterol levels. The method uses p-sitostanol, made from p-sitosterol by hydrogenating in an organic solvent in the presence of palladium on carbon as a catalyst, and a vegetable oil to produce an ester of p-sitostanol with a fatty acid, or a mixture of such esters, using the trans-esterification technique in the presence of a sodium ethylate catalyst.
Begge de ovennevnte patentsøknadene redegjør for en fremgangsmåte for å modifisere P-sitosterol for å oppnå et derivat av dette som er løselig i fettstoffer, der oppløselige p-sitostanolfettsyreestere produseres av dette, så vel som bruken av sammensetningene som oppnås som midler for å senke serumkolesterolnivåer. Both of the above patent applications disclose a process for modifying β-sitosterol to obtain a fat-soluble derivative thereof, wherein soluble β-sitostanol fatty acid esters are produced therefrom, as well as the use of the compositions obtained as agents for lowering serum cholesterol levels .
Naturlig forekommende p-sitosterol er en krystallinsk sammensetning. Som kjent løses frie steroler, som p-sitosterol, kun i liten grad i olje og fett, og derfor produseres derivater av p-sitosterol, for eksempel estere som er vesentlig mer fettløselige, av praktiske årsaker, selv om, ifølge noen studier (15), disse derivatene ikke hemmer absorpsjonen av kolesterol så effektivt som den frie p-sitosterol. Slike derivater som er løselige i fettstoffer kan blandes mye lettere inn i ernæringsprodukter for å forme en homogen blanding enn et solid, uoppløselig, grovt p-sitosterolpulver. En slik prosessering for å oppnå et P-sitosterolderivat medfører imidlertid ytterligere kostnader på produktet. Videre utføres nødvendigvis hydreringen av P-sitosterol til p-sitostanol ved hjelp av et organisk løsningsmiddel slik at spor av dette, så vel som spor av de metallkatalysatorene som benyttes, kan være tilstede i det forestrede sluttproduktet. I tillegg er ikke det forestrede produktet lenger en naturlig forekommende substans, men en menneskelaget kunstig kjemisk sammensetning. Naturally occurring p-sitosterol is a crystalline compound. As is known, free sterols, such as p-sitosterol, are only slightly soluble in oil and fat, and therefore derivatives of p-sitosterol, for example esters which are significantly more fat-soluble, are produced for practical reasons, although, according to some studies (15 ), these derivatives do not inhibit the absorption of cholesterol as effectively as the free p-sitosterol. Such fat-soluble derivatives can be mixed much more easily into nutritional products to form a homogeneous mixture than a solid, insoluble, coarse p-sitosterol powder. However, such processing to obtain a P-sitosterol derivative entails additional costs for the product. Furthermore, the hydrogenation of p-sitosterol to p-sitostanol is necessarily carried out using an organic solvent so that traces of this, as well as traces of the metal catalysts used, can be present in the esterified end product. In addition, the esterified product is no longer a naturally occurring substance, but a man-made artificial chemical composition.
US-A-3085939 vedrører olje-i-vann emulsjoner inneholdende umettet olje og sitosterol. JP-A-62148424 vedrører en sterolinneholdende sammensetning for næringsmiddel-industrien. US-A-3085939 relates to oil-in-water emulsions containing unsaturated oil and sitosterol. JP-A-62148424 relates to a sterol-containing composition for the food industry.
WO-A1-9742830 vedrører en sammensetning inneholdende en flytende fettkomponent og minst en sterol. WO-A1-9742830 relates to a composition containing a liquid fat component and at least one sterol.
Et formål med oppfinnelsen er å frembringe en fremgangsmåte for å produsere en fettblanding av P-sitosterol, som er gunstig for helsen, homogen og stabil, senker det totale serumkolesterol og LDL-kolesterolnivåene og inneholder P-sitosterol i en delvis oppløst og/eller i en mikrokrystallinsk form. Et annet formål med oppfinnelsen er å bruke en slik homogen stabil fettblanding av p-sitosterol som inneholder dette i en delvis oppløst og/eller i en mikrokrystallinsk form i fettpreparater eller matprodukter som et middel som senker kolesterolnivået i serum, så vel som å bruke denne blandingen som sådan for å komplementere dietten. An object of the invention is to produce a method for producing a fat mixture of P-sitosterol, which is beneficial for health, homogeneous and stable, lowers total serum cholesterol and LDL cholesterol levels and contains P-sitosterol in a partially dissolved and/or in a microcrystalline form. Another object of the invention is to use such a homogeneous stable fat mixture of p-sitosterol containing this in a partially dissolved and/or in a microcrystalline form in fat preparations or food products as an agent that lowers the cholesterol level in serum, as well as to use this the mixture as such to complement the diet.
Det er således frembragt en fremgangsmåte for å produsere en fettblanding av P-sitosterol, eller av p-sitosterol og p-sitostanol, som senker de serumtotale kolesterol- og LDL-kolesterolnivåene. Fremgangsmåten kjennetegnes ved at 10 - 30 vekt% av et startmateriale inneholdende p-sitosterol eller p-sitosterol og p-sitostanol løses i 5 - 90 vekt%, fortrinnsvis 60 - 85 vekt% av olje, fett, eller blandinger av oljer og fettstoffer, ved oppvarming ved en temperatur på 80 - 140°C inntil startmaterialet inneholdende p-sitosterol eller P-sitosterol og P-sitostanol er oppløst, hvorpå blandingen avkjøles til en temperatur på 40 - 80°C og der det i løpet av avkjølingen tilføres 5-30 vekt% av vann med en temperatur som i hovedsak er lik blandingens temperatur, til blandingen, og blandingen røres hvorved det oppnås en homogen og stabil blanding der startmaterialet inne-holdende p-sitosterol eller p-sitosterol og p-sitostanol er i en delvis oppløst og/eller mikrokrystallinsk form. A method has thus been produced for producing a fat mixture of P-sitosterol, or of p-sitosterol and p-sitostanol, which lowers the serum total cholesterol and LDL cholesterol levels. The method is characterized by the fact that 10 - 30% by weight of a starting material containing p-sitosterol or p-sitosterol and p-sitostanol is dissolved in 5 - 90% by weight, preferably 60 - 85% by weight of oil, fat, or mixtures of oils and fats, by heating at a temperature of 80 - 140°C until the starting material containing p-sitosterol or P-sitosterol and P-sitostanol is dissolved, after which the mixture is cooled to a temperature of 40 - 80°C and where during the cooling it is added 5- 30% by weight of water with a temperature which is essentially equal to the temperature of the mixture, to the mixture, and the mixture is stirred whereby a homogeneous and stable mixture is obtained where the starting material containing p-sitosterol or p-sitosterol and p-sitostanol is in a partial dissolved and/or microcrystalline form.
Foretrukne trekk ved fremgangsmåten ifølge oppfinnelsen fremgår av kravene 2-5. Preferred features of the method according to the invention appear from claims 2-5.
Det er videre frembragt en fettblanding inneholdende P-sitosterol, eller p-sitosterol og p-sitostanol, som senker serumtotalkolesterol- og LDL-kolesterolnivåene. Fettblandingen ifølge oppfinnelsen kjennetegnes ved at sammensetningen omfatter 10 - 30 vekt% av et startmateriale inneholdende P-sitosterol, eller p-sitosterol og p-sitostanol, 5-90 vekt%, fortrinnsvis 60 - 85 vekt% av olje eller fett eller blandinger av disse, og 5 - 30 vekt% vann, og at startmaterialet som inneholder P-sitosterol eller p-sitosterol og p-sitostanol er i en delvis oppløst og/eller mikrokrystallinsk form, og at sammen-setningen er stabil og homogen ved rom- og kjøleskapstemperaturer, basert på fysiske vurderinger og vurderinger ved hjelp av sansene. A fat mixture containing P-sitosterol, or p-sitosterol and p-sitostanol, has also been produced, which lowers serum total cholesterol and LDL cholesterol levels. The fat mixture according to the invention is characterized in that the composition comprises 10-30% by weight of a starting material containing P-sitosterol, or p-sitosterol and p-sitostanol, 5-90% by weight, preferably 60-85% by weight of oil or fat or mixtures of these , and 5 - 30% by weight of water, and that the starting material containing p-sitosterol or p-sitosterol and p-sitostanol is in a partially dissolved and/or microcrystalline form, and that the composition is stable and homogeneous at room and refrigerator temperatures , based on physical assessments and assessments using the senses.
Foretrukne trekk ved fettblandingen ifølge oppfinnelsen fremgår av kravene 7 -10. Preferred features of the fat mixture according to the invention appear from claims 7-10.
Det er videre frembragt en fremgangsmåte for tilføring av P-sitosterol, eller P-sitosterol og p-sitostanol, for å senke serumtotale kolesterol- og LDL-kolesterolnivåer, i matvareprodukter. Fremgangsmåten ifølge oppfinnelsen kjennetegnes ved at 10 - 30 vekt% av et startmateriale inneholdende p-sitosterol eller p-sitosterol og p-sitostanol løses i 5 - 90 vekt%, fortrinnsvis 60 - 85 vekt% olje, fett eller blandinger av disse ved oppvarming ved en temperatur på 80 - 140°C inntil startmaterialet inneholdende p-sitosterol eller p-sitosterol og P-sitostanol er oppløst, hvorpå blandingen avkjøles til en temperatur på 40 - 80°C og der det i løpet av avkjølingen tilføres 5-30 vekt% vann med en temperatur som i hovedsak er lik blandingens temperatur, til blandingen, og der blandingen omrøres hvorved det oppnås en homogen og stabil blanding der startmaterialet inneholdende p-sitosterol eller p-sitosterol og p-sitostanol er i en delvis oppløst og/eller mikrokrystallinsk form, og der den resulterende blandingen blandes i matingredienser i en matproduksjonsprosess. A method has also been developed for adding P-sitosterol, or P-sitosterol and p-sitostanol, to lower serum total cholesterol and LDL cholesterol levels in food products. The method according to the invention is characterized by the fact that 10 - 30% by weight of a starting material containing p-sitosterol or p-sitosterol and p-sitostanol is dissolved in 5 - 90% by weight, preferably 60 - 85% by weight of oil, fat or mixtures thereof by heating at a temperature of 80 - 140°C until the starting material containing p-sitosterol or p-sitosterol and P-sitostanol is dissolved, after which the mixture is cooled to a temperature of 40 - 80°C and where 5-30% by weight is added during the cooling water with a temperature which is essentially equal to the temperature of the mixture, to the mixture, and where the mixture is stirred whereby a homogeneous and stable mixture is obtained where the starting material containing p-sitosterol or p-sitosterol and p-sitostanol is in a partially dissolved and/or microcrystalline form, and where the resulting mixture is mixed into food ingredients in a food production process.
Anvendelser av fettblandingen ifølge oppfinnelsen fremgår av kravene 11 og 12. Applications of the fat mixture according to the invention appear from claims 11 and 12.
Vi har funnet at P-sitosterol kan gjøres delvis løselig og/eller mikrokrystallinsk med den følgende prosedyre. Problemene og ulempene assosiert med den kjente teknikk kan unngås med løsningen ifølge den foreliggende oppfinnelse. Ifølge oppfinnelsens fremgangsmåte blandes p-sitosterol og matolje, og denne blandingen varmes til alle faste stoffer er oppløst i oljen. Etter avkjøling, tilføres vann til blandingen ved dennes temperatur for derved å dispergere denne. Resultatet vil være en homogen, stabil, fett-lignende, så å si hvit masse med en konsistens som minner mye om smør, eller en oljet blanding, avhengig av komponentenes mengder. Denne homogene og stabile deigen er spesielt egnet for å bli blandet inn i for eksempel matprodukter. We have found that P-sitosterol can be made partially soluble and/or microcrystalline by the following procedure. The problems and disadvantages associated with the known technique can be avoided with the solution according to the present invention. According to the method of the invention, p-sitosterol and cooking oil are mixed, and this mixture is heated until all solids are dissolved in the oil. After cooling, water is added to the mixture at its temperature to thereby disperse it. The result will be a homogenous, stable, fat-like, so to speak, white mass with a consistency very reminiscent of butter, or an oily mixture, depending on the amounts of the components. This homogeneous and stable dough is particularly suitable for being mixed into, for example, food products.
Startmaterialet i denne fremgangsmåten er p-sitosterol som kan inneholde 80- 100% av P-sitosterol og P-sitostanol, og som urenheter 0 - 20% av andre steroler og stanoler. Dette startmaterialet inneholder p-sitosterol, eller P-sitosterol kan blandes med matoljen med en mengde på om lag 0,5 - 80%, fortrinnsvis 10 - 30%, der det resulterende deig-aktige produktet har en fremtoning og en viskositet som er svært lik de samme egenskapene til smør, og er svært lett å håndtere. Jo høyere prosent p-sitosterol i blandingen, desto hardere vil massen være. På den andre side, dersom mengden p-sitosterol i blandingen er mindre enn 10% beregnet ut fra mengden olje, vil massens viskositet avta, og konsistensen av denne vil klart være mer liknende en oljekonsistens. Som en matolje, kan enhver matlagningsolje eller enhver matolje eller fett, eller olje eller en oljesammensetning av animalsk opphav, og egnet for menneskelig konsum, benyttes, for eksempel torskeleverolje, eller enhver spiselig oljesubstans av plante- eller animalsk opphav, eller blandinger av disse. Foretrukne oljer er rapsolje, turnipsolje, solsikkeolje, soyaolje, maisolje og olivenolje. Mengden olje er 5 - 90%, fortrinnsvis 60 - 85% i forhold til blandingens masse. The starting material in this method is p-sitosterol, which can contain 80-100% of P-sitosterol and P-sitostanol, and as impurities 0-20% of other sterols and stanols. This starting material contains p-sitosterol, or p-sitosterol can be mixed with the cooking oil in an amount of about 0.5 - 80%, preferably 10 - 30%, where the resulting dough-like product has an appearance and a viscosity that is very similar to the properties of butter, and is very easy to handle. The higher the percentage of p-sitosterol in the mixture, the harder the mass will be. On the other hand, if the amount of p-sitosterol in the mixture is less than 10% calculated from the amount of oil, the viscosity of the mass will decrease, and the consistency of this will clearly be more like an oil consistency. As a cooking oil, any cooking oil or any cooking oil or fat, or oil or an oil composition of animal origin, and suitable for human consumption, can be used, for example cod liver oil, or any edible oily substance of vegetable or animal origin, or mixtures thereof. Preferred oils are rapeseed oil, rapeseed oil, sunflower oil, soya oil, corn oil and olive oil. The amount of oil is 5 - 90%, preferably 60 - 85% in relation to the mass of the mixture.
I denne fremgangsmåten, varmes en blanding av startmaterialet som inneholder p-sitosterol og olje ved en temperatur på 80 - 140°C, fortrinnsvis 100 - 120°C, inntil det faste startmaterialet som inneholder P-sitosterol er oppløst i oljen. Etter at blandingen er avkjølt på en kjent måte til en temperatur på 40 - 80°C, fortrinnsvis til 50 - 70°C, tilføres vann som i hovedsak har den samme temperatur som blandingen. Tekstur-stabiliserende overflateaktive midler, så som polysorbat (Tween 80, Polysorbat 80), egglekitin, eller soyabønnelekitin, kjent som emulgeringsmidler, kan som en opsjon tilføres blandingen med en mengde på 0,05 til 8 vekt%. Om nødvendig kan det tilføres stabiliseirngsmidler, antioksydanter eller andre egnede mattilsetningsstoffer som er kjent teknikk, så som natriumklorid, mineralsalt, preserverings- og aromastoffer, og/eller ulike vitaminer, for eksempel A-vitaminer og E-vitaminer, matfargestoff og pytofenoler. Den blandingen som på den måten lages er homogen og stabil under konvensjonelle forhold for oppbevaring av matprodukter. I denne blandingen er p-sitosterolet i en delvis oppløst og/eller mikrokrystallinsk form. Om nødvendig, kan p-sitosterol også løses i en olje som beskrevet over, og denne blandingen av P-sitosterol og olje kan benyttes som sådan i matvareproduksjon. In this method, a mixture of the starting material containing p-sitosterol and oil is heated at a temperature of 80 - 140°C, preferably 100 - 120°C, until the solid starting material containing p-sitosterol is dissolved in the oil. After the mixture has been cooled in a known manner to a temperature of 40 - 80°C, preferably to 50 - 70°C, water is added which essentially has the same temperature as the mixture. Texture-stabilizing surfactants, such as polysorbate (Tween 80, Polysorbate 80), egg lecithin, or soybean lecithin, known as emulsifiers, can optionally be added to the mixture in an amount of 0.05 to 8% by weight. If necessary, stabilizers, antioxidants or other suitable food additives known in the art can be added, such as sodium chloride, mineral salt, preservatives and flavourings, and/or various vitamins, for example vitamins A and E, food coloring and phytophenols. The mixture thus created is homogeneous and stable under conventional conditions for storing food products. In this mixture, the p-sitosterol is in a partially dissolved and/or microcrystalline form. If necessary, p-sitosterol can also be dissolved in an oil as described above, and this mixture of P-sitosterol and oil can be used as such in food production.
Fremgangsmåten ifølge oppfinnelsen gjør det mulig å produsere på en enkel og økonomisk måte, en fettblanding av P-sitosterol som gavner helsen, som er homogen og stabil og som reduserer kolestorolabsorpsjonen i tarmen, for derved å senke de serumtotale kolesterol- og LDL-kolesterolnivåene, og inneholder P-sitosterolet i en delvis oppløst og/eller mikrokrystallinsk form. Denne fremgangsmåten benytter et naturlig forekommende p-sitosterol, og en matolje eller fett, uten noen organiske løsnings-midler eller kompliserte prosesstrinn. Selv store doser av den resulterende homogene stabile fettblandingen som inneholder et naturlig forekommende p-sitosterol kan trygt konsumeres gjennom matvareprodukter daglig, og benyttes i matproduksjon og matlaging for å erstatte fett delvis eller i sin helhet. P-sitosterol kan ikke detekteres ved hjelp av sansene fra andre matvareprodukter. Ved hjelp av de matvareproduktene som er preparert på denne måten, kan kolesterolabsorpsjon i tarmen hemmes, og de totale serumkolesterol- og LDL-kolesterolnivåene kan senkes signifikant. I tillegg, da p-sitosterol som erstatter fett ikke absorberes vesentlig, reduseres andelen absorbert fett, og dermed senkes energiinntaket. The method according to the invention makes it possible to produce, in a simple and economic way, a fat mixture of P-sitosterol which benefits health, which is homogeneous and stable and which reduces cholesterol absorption in the intestine, thereby lowering serum total cholesterol and LDL cholesterol levels, and contains the P-sitosterol in a partially dissolved and/or microcrystalline form. This method uses a naturally occurring p-sitosterol, and a cooking oil or fat, without any organic solvents or complicated process steps. Even large doses of the resulting homogeneous stable fat mixture containing a naturally occurring p-sitosterol can be safely consumed through food products on a daily basis, and used in food production and cooking to replace fat in part or in full. P-sitosterol cannot be detected using the senses from other food products. With the help of the food products prepared in this way, cholesterol absorption in the intestine can be inhibited, and the total serum cholesterol and LDL cholesterol levels can be significantly lowered. In addition, since p-sitosterol, which replaces fat, is not absorbed significantly, the proportion of absorbed fat is reduced, and thus energy intake is lowered.
En fettblanding som inneholder P-sitosterol kan tilføres matprodukter som inneholder animalske eller vegetabilske oljer, eller blandinger av disse. Egnede matprodukter er ulike prosesserte kjøttprodukter, så som pølser og oppskåret pålegg, prosesserte fiske-produkter, matprodukter som inneholder naturlige fettsyrer, meieriprodukter så som ost, og flere andre matprodukter som inneholder spiselige fettstoffer eller blandinger av slike, som for eksempel sauser og dressinger, majones, krydder og krydderblandinger, kornblandinger, nudler og pastaprodukter, iskrem, sukkertøy, sjokolade, kaker, bakverk og lignende, så vel som spiselig fett for matlaging og baking, og blandinger av disse. A fat mixture containing P-sitosterol can be added to food products containing animal or vegetable oils, or mixtures thereof. Suitable food products are various processed meat products, such as sausages and sliced meats, processed fish products, food products that contain natural fatty acids, dairy products such as cheese, and several other food products that contain edible fats or mixtures thereof, such as sauces and dressings, mayonnaise, spices and spice mixtures, cereals, noodles and pasta products, ice cream, confectionery, chocolate, cakes, pastries and the like, as well as edible fats for cooking and baking, and mixtures thereof.
Oppfinnelsen vil nå illustreres ved hjelp av noen foretrukne utførelsesformer som er beskrevet i de følgende eksemplene. Disse eksemplene har imidlertid ikke til hensikt å begrense oppfinnelsen kun til disse. The invention will now be illustrated by means of some preferred embodiments which are described in the following examples. However, these examples are not intended to limit the invention only to these.
Eksempler. Examples.
Fremgangsmåte for å produsere en blanding av p-sitosterol og fett, dvs. en såkalt grunnblanding. Method for producing a mixture of p-sitosterol and fat, i.e. a so-called basic mixture.
I eksemplene var startmaterialet en blanding som inneholdt p-sitosterol og p-sitostanol i en total mengde på 89,2%, a-sitosterol med en mengde på 0,1%, kampesterol og kampestanol i en total mengde på 8,9% og artenoler med en total mengde på 0,9%. Startmaterialet hadde en faststoffandel på 98,8%, et smelteområde på 137 - 138°C og en tetthet på 0,49 kg/dm<3>. For enkelhets skyld, er dette startmaterialet omtalt i det følgende som "startmaterialet som inneholder p-sitosterol" ifølge dennes hovedkomponent. In the examples, the starting material was a mixture containing p-sitosterol and p-sitostanol in a total amount of 89.2%, α-sitosterol in an amount of 0.1%, campesterol and campestanol in a total amount of 8.9% and artenols with a total amount of 0.9%. The starting material had a solids content of 98.8%, a melting range of 137 - 138°C and a density of 0.49 kg/dm<3>. For the sake of simplicity, this starting material is referred to in the following as "starting material containing p-sitosterol" according to its main component.
Eksempel 1. Grunnblanding inneholdende p-sitosterol. Example 1. Basic mixture containing p-sitosterol.
En blanding inneholdende 20 vekt% P-sitosterol og 80 vekt% rapsolje ble laget. Blandingen ble oppvarmet under omrøring i en glasskrukke inntil startmaterialet som inneholder p-sitosterol var oppløst i oljen. På det punktet var temperaturen om lag 110°C, og testen ble utført ved normalt atmosfærisk trykk. A mixture containing 20 wt% P-sitosterol and 80 wt% rapeseed oil was made. The mixture was heated with stirring in a glass jar until the starting material containing p-sitosterol was dissolved in the oil. At that point the temperature was about 110°C, and the test was carried out at normal atmospheric pressure.
Etter at blandingen var avkjølt til om lag 60°C, ble springvann med samme temperatur som blandingen (60°C) tilført denne med en mengde på om lag 15% i forhold til blandingens mengde, finmalt i en morter. After the mixture had cooled to about 60°C, tap water at the same temperature as the mixture (60°C) was added to it in an amount of about 15% in relation to the amount of the mixture, finely ground in a mortar.
Blandingen var i utgangspunktet gjennomsiktig og oljegul da den ble undersøkt visuelt. Da tilføringen av vann nesten var sluttført, ble plutselig blandingen ugjennomsiktig og nesten hvit. Blandingen fikk avkjøle seg til romtemperatur (22°C) under omrøring. Den endelige sammensetningen av blandingen er vist i tabell 1. The mixture was initially transparent and oily yellow when examined visually. When the addition of water was almost complete, the mixture suddenly became opaque and almost white. The mixture was allowed to cool to room temperature (22°C) with stirring. The final composition of the mixture is shown in Table 1.
Basert på en undersøkelse ved hjelp av sansene, var blandingen i tabell 1 en hvit, fet masse, med en konsistens som minnet svært om smør, og inneholdende p-sitosterol i en delvis oppløst og/eller mikrokrystallinsk form. Blandingen var praktisk talt uten smak. Når den har blitt lagret i et kjøleskap, har grunnblandingen i tabell 1 forblitt uendret, basert på det som kan oppfattes ved hjelp av sansene. Hittil har blandingen vært lagret i om lag 6 måneder. Based on an examination by the senses, the mixture in Table 1 was a white, oily mass, with a consistency very similar to butter, and containing p-sitosterol in a partially dissolved and/or microcrystalline form. The mixture was practically tasteless. When stored in a refrigerator, the base mixture in Table 1 has remained unchanged, based on what can be perceived by the senses. So far, the mixture has been stored for about 6 months.
Eksempel 2 Example 2
Variasjon av konsentrasjonene av startmaterialet inneholdende P-sitosterol i blandingen inneholdende olje og vann Variation of the concentrations of the starting material containing P-sitosterol in the mixture containing oil and water
I fremgangsmåten i eksempel 1, ble blandinger laget der andelen av startmaterialet inneholdende P-sitosterol var 2,5 - 60% av rapsolje. Man observerte at grunn-blandingens konsistens var mest å foretrekke når startmaterialet inneholdende P-sitosterolkonsentrasjonen var mellom 10% og 20%. Blandingen har da en fremtreden og en viskositet som kan sammenlignes med smør, og er lett å håndtere. In the method in example 1, mixtures were made in which the proportion of the starting material containing P-sitosterol was 2.5 - 60% of rapeseed oil. It was observed that the consistency of the base mixture was most preferable when the starting material containing the P-sitosterol concentration was between 10% and 20%. The mixture then has an appearance and a viscosity comparable to butter, and is easy to handle.
Desto høyere andelen i blandingen er av startmaterialet inneholdende p-sitosterol, desto hardere vil blandingens konsistens være. På tross av blandingens hardhet, kan selv høye andeler av startmateriale inneholdende p-sitosterol benyttes, som beskrevet i eksempel II (tilførsel av startmaterialet inneholdende p-sitosterol til et pastaprodukt). The higher the proportion in the mixture of the starting material containing p-sitosterol, the harder the consistency of the mixture will be. Despite the hardness of the mixture, even high proportions of starting material containing p-sitosterol can be used, as described in example II (supply of starting material containing p-sitosterol to a pasta product).
Eksempel 3 Example 3
Tilberedning av blandingen ved bruk av ulike matoljer Preparation of the mixture using different cooking oils
Med fremgangsmåten i eksempel 1, ble blandinger tillaget der rapsolje ble erstattet med solsikkeolje, maisolje og olivenolje. Blandinger ble laget med hver av disse oljene der det ble brukt tre ulike prosentandeler p-sitosterol: 5%, 10% og 20%. Using the procedure in Example 1, mixtures were prepared in which rapeseed oil was replaced by sunflower oil, corn oil and olive oil. Blends were made with each of these oils using three different percentages of p-sitosterol: 5%, 10% and 20%.
Basert på en undersøkelse ved hjelp av sansene og ved hjelp av mikroskop, var blandingene like med de som ble laget med rapsolje, med unntak av at den blandingen som inneholdt olivenolje hadde en grønnaktig farge. Dette tyder på at alle matoljer er svært egnet for bruk i fremgangsmåten ifølge oppfinnelsen. Based on sensory and microscopic examination, the mixtures were similar to those made with rapeseed oil, except that the mixture containing olive oil had a greenish color. This suggests that all edible oils are very suitable for use in the method according to the invention.
Eksempel 4 Example 4
Tilførsel av et overflateaktivt middel til grunnblandingen i eksempel 1 Addition of a surfactant to the basic mixture in example 1
Det er generelt kjent at overflateaktive midler er nødvendig for tillagingen og stabiliseringen av disperse systemer, spesielt emulsjoner. Det er ofte viktig å benytte overflateaktive midler som er i stand til å stabilisere dispersjonenes konsistent, spesielt for langvarig lagring, for eksempel for å forhindre enhver separasjon av emulsjons-komponentene, eller en krystallisering av disse. It is generally known that surfactants are necessary for the preparation and stabilization of disperse systems, especially emulsions. It is often important to use surfactants which are able to stabilize the consistency of the dispersions, especially for long-term storage, for example to prevent any separation of the emulsion components, or a crystallization thereof.
Blandingene i eksempel 1 ble i hovedsak laget, inneholdende 2 vekt%, beregnet fra andelen av vannfasen, av emulgator vanligvis kjent som overflateaktive midler så som polysorbat (Tween 80, Polysorbat 80), egglekitin eller soyabønnelekitin. De resulterende sammensetningene var essensielt som vist i tabell I, men inneholdende om lag 0,3 vekt% av et overflateaktivt middel. The mixtures in Example 1 were essentially made, containing 2% by weight, calculated from the proportion of the water phase, of emulsifier commonly known as surfactants such as polysorbate (Tween 80, Polysorbate 80), egg lecithin or soybean lecithin. The resulting compositions were essentially as shown in Table I, but containing about 0.3% by weight of a surfactant.
Tilførsel av en fettblanding inneholdende P-sitosterol til et matvareprodukt. Supply of a fat mixture containing P-sitosterol to a food product.
Eksempel 5 Example 5
Tilførsel av den blandingen beskrevet i eksempel 1 i tradisjonelt kommersielt tilgjengelig smør. 50 vekt% av grunnblandingen ifølge eksempel 1 og 50 vekt% smør ("Meijerivoi of Valio", med lavt saltinnhold) ble blandet i en vanlig stålmorter ved romtemperatur (om lag 22°C). Blandingen ble lett utført uten noen form for vanskeligheter. Supplying the mixture described in Example 1 in traditional commercially available butter. 50% by weight of the basic mixture according to example 1 and 50% by weight of butter ("Meijerivoi of Valio", with a low salt content) were mixed in an ordinary steel mortar at room temperature (about 22°C). The mixing was easily done without any kind of difficulty.
Basert på en evaluering ved hjelp av sansene, var resultatet en jevn, lysegul masse med farge lik smør som føltes som ordinært smør på alle måter. Blandingens smak var god og kunne ikke skilles fra smaken av ekte smør, med mulig unntak for et noe lavere saltinnhold. Based on an evaluation by the senses, the result was a smooth, pale yellow mass with a color similar to butter that felt like ordinary butter in every way. The taste of the mixture was good and could not be distinguished from the taste of real butter, with the possible exception of a somewhat lower salt content.
Eksempel 6 Example 6
Tilførsel av blandingen beskrevet i eksempel 1 i en konvensjonell kommersielt tilgjengelig rapsmargarin 50 vekt% av grunnblandingen ifølge eksempel 1 og 50 vekt% av rapsmargarin ("Kultarypsi margariini 60", Van der Bergh, Sverige) ble blandet sammen i en ordinær stålmorter ved romtemperatur (om lag 22°C). Blandingen var noe mykere, men ellers med en konsistens tilsvarende den i eksempel 3 over. Blandingen ble lett utført uten noen vanskeligheter. Supply of the mixture described in example 1 in a conventional commercially available rapeseed margarine 50% by weight of the base mixture according to example 1 and 50% by weight of rapeseed margarine ("Kultarypsi margariini 60", Van der Bergh, Sweden) were mixed together in an ordinary steel mortar at room temperature ( about 22°C). The mixture was somewhat softer, but otherwise with a consistency similar to that in example 3 above. The mixing was easily done without any difficulty.
Basert på en vurdering ved hjelp av sansene, var resultatet en jevn, lysegul masse med farge lik original rapsmargarin som føltes som ordinær rapsmargarin på alle måter. Smaken av den resulterende var god og kunne ikke skilles fra smaken av den initielle margarinen, med mulig unntak for et noe lavere saltinnhold. Based on an assessment by the senses, the result was a smooth, pale yellow mass with a color similar to original canola margarine that felt like ordinary canola margarine in every way. The taste of the resulting product was good and indistinguishable from the taste of the initial margarine, with the possible exception of a somewhat lower salt content.
Eksempel 7 Example 7
Tilførsel av blandingen beskrevet i eksempel 1 i ordinært kommersielt tilgjengelig lettmargarin (light spread). 50 vekt% av grunnblandingen i eksempel 1 og 50 vekt% av lettmargarin ("Kevyt Voilevi 40%" fra Valio med et lavt saltinnhold) ble blandet sammen i en ordinær stålmorter. Blandingen ble utført lett og uten problemer. Supply of the mixture described in example 1 in ordinary commercially available light margarine (light spread). 50% by weight of the base mixture in example 1 and 50% by weight of light margarine ("Kevyt Voilevi 40%" from Valio with a low salt content) were mixed together in an ordinary steel mortar. Mixing was done easily and without problems.
Basert på en vurdering ved hjelp av sansene, var resultatet en jevn masse med en lysegul farge og en gjennomgående følelse lik den initielle lettmargarinen som ble benyttet. Smaken av den resulterende blandingen var god, og kunne praktisk talt ikke skilles fra smaken av den opprinnelige margarinen, med mulig unntak av et noe lavere saltinnhold. Based on a sensory assessment, the result was a smooth mass with a pale yellow color and a consistent feel similar to the initial light margarine used. The taste of the resulting mixture was good, and practically indistinguishable from the taste of the original margarine, with the possible exception of a somewhat lower salt content.
Eksempel 8 Example 8
Tilførsel av salt (natriumklorid) til blandinger tillaget som beskrevet i eksemplene log 2. Addition of salt (sodium chloride) to mixtures prepared as described in examples log 2.
Blandinger ble laget som beskrevet i eksemplene 1 og 2, og det ble tilført 0,9% natriumklorid i forhold til massens endelige vekt, ved hjelp av en kjent fremgangsmåte. Basert på en vurdering ved hjelp av sansene, forringet ikke tilførselen av salt disse grunn-blandingenes egenskaper på noen måte. Mixtures were made as described in examples 1 and 2, and 0.9% sodium chloride was added in relation to the final weight of the mass, using a known method. Based on a sensory assessment, the addition of salt did not impair the properties of these base mixes in any way.
Eksempel 9 Example 9
Vurdering av stekeegenskapene til de massene som er beskrevet over Assessment of the frying properties of the masses described above
Oppførselen til de blandingene som inneholder smør eller vegetabilsk margarin som er beskrevet i eksemplene 5 og 6 ble studert ved simulert steking ved at de ble stekt i begre. Steking av rent smør og margarin ble også studert, for sammenligningens skyld. Blandingen som inneholdt lettmargarin ble ikke stekt fordi lettmargarin brukt som et startmateriale er ikke tiltenkt steking. The behavior of the mixtures containing butter or vegetable margarine described in Examples 5 and 6 was studied by simulated frying by frying them in cups. Frying pure butter and margarine was also studied, for the sake of comparison. The mixture containing light margarine was not fried because light margarine used as a starting material is not intended for frying.
9. 1 Smør som sådan 9. 1 Butter as such
Initielt, da rent smør ble oppvarmet, dannet dette en sterkt gul olje med lite bobler. Når oppvarmingen fortsatte, opptrådte brune utfelte lag. Dette er hvordan smør vanligvis blir brunt. Initially, when pure butter was heated, it formed a bright yellow oil with few bubbles. As heating continued, brown precipitates appeared. This is how butter usually turns brown.
9. 2 Blanding inneholdende smør og p- sitosterol 9. 2 Mixture containing butter and p-sitosterol
Når man stekte blandingen i eksempel 5 smeltet den noe langsommere og freste mer enn smør som ble oppvarmet på samme måte. På samme måte som smør dannet det seg en sterkt gulfarget olje. Når oppvarmingen fortsatte, opptrådte det brune flekker med samme farge som de flekkene som opptrådte i smøret, men med en mindre størrelse. Dette antyder at nevnte blanding i eksempel 5 er like egnet for steking som kommersielle tilgjengelige smørtyper. When frying the mixture in Example 5, it melted somewhat more slowly and melted more than butter heated in the same way. In the same way as butter, a strongly yellow colored oil formed. As the heating continued, brown spots of the same color as those appearing in the butter, but of a smaller size, appeared. This suggests that said mixture in example 5 is just as suitable for frying as commercially available types of butter.
9. 3 Margarin som sådan 9. 3 Margarine as such
Ren margarin dannet også en klar gulfarget olje når det smeltet. Det freste mer enn smør når det ble oppvarmet. Ved oppvarming fremkom brune flekker, som i blandingen i eksempel 5 som inneholdt smør og grunnblandingen i eksempel 1. Pure margarine also formed a clear yellow colored oil when melted. It melted more than butter when heated. When heated, brown spots appeared, as in the mixture in example 5 which contained butter and the base mixture in example 1.
9. 4 Blanding inneholdende margarin og p- sitosterol 9. 4 Mixture containing margarine and p-sitosterol
Når blandingen i eksempel 6 ble stekt, observerte man at det oppførte seg i steketesten på samme måte som ren margarin og i det alt vesentlige på samme måte som blandingen i eksempel 5. Dette tyder på at blandingen er like egnet for oppvarming som kommersielt tilgjengelige margarintyper. When the mixture in Example 6 was fried, it was observed that it behaved in the frying test in the same way as pure margarine and essentially in the same way as the mixture in Example 5. This indicates that the mixture is as suitable for heating as commercially available margarine types .
9. 5 Konklusjoner på testene i eksempel 9 9. 5 Conclusions on the tests in example 9
I denne steketesten, lot forskjellene i fettbruningen til å være på grunn av den typen fett som ble brukt (smør eller rapsmargarin), og skyldtes ikke tilstedeværelsen av grunnblandingen inneholdende P-sitosterol. In this frying test, the differences in fat browning appeared to be due to the type of fat used (butter or canola margarine) and were not due to the presence of the base mixture containing P-sitosterol.
Eksempel 10 Example 10
Tilførsel av blandingen beskrevet i eksempel 1 til meieriprodukter Supply of the mixture described in example 1 to dairy products
50 vekt% av grunnblandingen i eksempel 1 og 50 vekt% av majones (Heinz Mayonnaise, H.J. Heinz B.V., Holland) ble blandet sammen i en ordinær stålmorter ved romtemperatur (om lag 22°C). Blandingen ble blandet sammen på samme måte som med et rømmeprodukt (Smetana fra Valio) og med et kremostprodukt (Hovi kremost fra Valio). Blandingen av disse matvareproduktene ble utført lett og uten vanskeligheter av noe slag. 50% by weight of the base mixture in example 1 and 50% by weight of mayonnaise (Heinz Mayonnaise, H.J. Heinz B.V., Holland) were mixed together in an ordinary steel mortar at room temperature (about 22°C). The mixture was mixed together in the same way as with a sour cream product (Smetana from Valio) and with a cream cheese product (Hovi cream cheese from Valio). The mixing of these food products was carried out easily and without difficulty of any kind.
Eksempel 11 Example 11
Tilførsel av startmaterialet inneholdende P-sitosterol til et pastaprodukt Supply of the starting material containing P-sitosterol to a pasta product
P-sitosterol ble varmet opp med den oljemengden som er nødvendig for pastatil-beredelse inntil enten p-sitosterol løste seg i olje, eller det ble dannet en opaliserende ensartet strømmende væske, avhengig av forholdet mellom p-sitosterol og olje. Denne væsken lot man avkjøles mens den ble finmalt. Den resulterende avkjølte blandingen ble enten tilført vann, eller en eggblanding og vann, eller en eggblanding mens man samtidig finmalte for å lage en emulsjon. En passende mengde durumhvetemel (hard hvete) og salt ble deretter tilført ved at deigen ble knadd. Vann ble tilført etter behov mens deigen ble knadd. Resultatet var en ensartet pasta der P-sitosterol verken kunne detekteres visuelt eller smakes. Mengden p-sitosterol i pastaen var så mye som 2 g/100 g fersk pasta. Mengder som overstiger dette er ikke nødvendig tatt i betraktning vekten av en pastaporsjon (125 g fersk pasta pr. porsjon) og når man tar i betraktning den passende konsentrasjonen P-sitosterol for aktiviseringen av denne. Tabell 2 viser eksempler på pastadeigsammensetninger. β-sitosterol was heated with the amount of oil necessary for paste preparation until either β-sitosterol dissolved in oil or an opalescent uniform flowing liquid was formed, depending on the ratio of β-sitosterol to oil. This liquid was allowed to cool while it was finely ground. The resulting cooled mixture was added with either water, or an egg mixture and water, or an egg mixture while simultaneously grinding to create an emulsion. An appropriate amount of durum wheat flour (hard wheat) and salt was then added by kneading the dough. Water was added as needed while the dough was being kneaded. The result was a uniform paste in which P-sitosterol could neither be detected visually nor tasted. The amount of p-sitosterol in the pasta was as much as 2 g/100 g of fresh pasta. Amounts exceeding this are not necessary, taking into account the weight of a portion of pasta (125 g of fresh pasta per portion) and when taking into account the appropriate concentration of P-sitosterol for its activation. Table 2 shows examples of pasta dough compositions.
Pastaflak ble laget på vanlig måte av denne pastadeigen. Pastaen kan serveres enten Pasta flakes were made in the usual way from this pasta dough. The pasta can be served either
som fersk pasta eller den kan tørkes for langvarig oppbevaring. Både ferske og tørkede pastaprodukter ble kokt i rikelig med vann for så lenge som 10 minutter. P-sitosterol ble ikke frigjort fra pastaen verken inn i det kokende vannet eller i det skyllevannet som ble brukt på den kokte pastaen. as fresh pasta or it can be dried for long-term storage. Both fresh and dried pasta products were boiled in plenty of water for as long as 10 minutes. P-sitosterol was not released from the pasta either into the boiling water or into the rinse water used on the cooked pasta.
Pastaens egenskaper samsvarte fullstendig med egenskapene til ordinær pasta tilberedt uten P-sitosterol. The properties of the pasta corresponded completely to those of ordinary pasta prepared without P-sitosterol.
1) Passende vannmengde kan variere avhengig av for eksempel typen av durumhvetemel. 1) The appropriate amount of water may vary depending on, for example, the type of durum wheat flour.
Eksempel 12 Example 12
Tilførsel av grunnblandingen inneholdende P-sitosterol i pizza Supply of the base mixture containing P-sitosterol in pizza
Pizzaene ble stekt ved 225°C i om lag 25 - 30 minutter. The pizzas were baked at 225°C for about 25 - 30 minutes.
Egenskapene til den pizzaen som inneholdt P-sitosterol tilsvarte fullstendig egenskapene til den pizzaen som ble laget uten p-sitosterol. The properties of the pizza containing β-sitosterol completely corresponded to the properties of the pizza made without β-sitosterol.
Eksempel 13 Example 13
Tilførsel av grunnblandingen inneholdende p-sitosterol i kjøttboller Supply of the base mixture containing p-sitosterol in meatballs
Kjøttblandingen klebet seg ikke til hendene, og egenskapene til de kjøttbollene som inneholdt p-sitosterol var sammenlignbare med egenskapene til de ordinære kjøttbollene uten p<->sitosterol. The meat mixture did not stick to the hands, and the properties of the meatballs containing p-sitosterol were comparable to the properties of the ordinary meatballs without p<->sitosterol.
Eksempel 14 Example 14
Tilførsel av grunnblandingen inneholdende P-sitosterol til rundstykker Supply of the base mixture containing P-sitosterol to rolls
Grunnblandingen som inneholder p-sitosterol kunne svært godt blandes i deigen og deigen var lett å håndtere og kna, da den ikke var klebrig. Egenskapene til de rundstykkene som inneholdt P-sitosterol samsvarte fullstendig med egenskapene til de rundstykkene som var laget uten P-sitosterol. The base mixture containing p-sitosterol could very well be mixed into the dough and the dough was easy to handle and knead, as it was not sticky. The properties of the rolls containing P-sitosterol completely matched the properties of the rolls made without P-sitosterol.
Eksempel 15 Example 15
Tilførsel av grunnblandingen som inneholder P-sitosterol til en saus laget med melk Adding the base mixture containing P-sitosterol to a sauce made with milk
Fett ble smeltet i en kasserolle, og mel ble deretter blandet i. Blandingen ble kokt opp, og kald melk ble tilført i to porsjoner. Fettet ble godt og jevnt blandet i sausen. Egenskapene til den melkaktige sausen der fettet ble erstattet med grunnblandingen inneholdende p-sitosterol samsvarte fullstendig med egenskapene til sausen som ble fremstilt ved bruk av ordinært fett. Fat was melted in a saucepan, and flour was then mixed in. The mixture was brought to a boil, and cold milk was added in two portions. The fat was well and evenly mixed into the sauce. The properties of the milky sauce in which the fat was replaced with the base mixture containing p-sitosterol fully corresponded to the properties of the sauce prepared using ordinary fat.
Henvisninger: References:
1) Jousiiahti P, Vartiainen E. Tuomiiehto J, Puska P: The Lancet 348/9027), pp. 567-572. 1996 2) Claus EP, Tyler VE & Brady LR: Pharmacognosy 6th edition. Lea & Febiger, London, 1970, pp. 165—157 3) Jones PJH et al. : Canadian Journal of Physiology & Pharmacology 75(3): 217-227, 1997 1) Jousiiahti P, Vartiainen E. Tuomiiehto J, Puska P: The Lancet 348/9027), pp. 567-572. 1996 2) Claus EP, Tyler VE & Brady LR: Pharmacognosy 6th edition. Lea & Febiger, London, 1970, pp. 165-157 3) Jones PJH et al. : Canadian Journal of Physiology & Pharmacology 75(3): 217-227, 1997
4) Pollak OJ, Kriichecsky D: Monogr Atheroscler. 10: 1—219. 1981 4) Pollak OJ, Kriichecsky D: Monogr Atheroscler. 10: 1—219. 1981
5) Vahoyny GV, Kritchavsky D.: Plant and marine sterols and cholesterol metabolism. ln Spiller GA, ed. Nutritional Pharmacology. New York, NY: 5) Vahoyny GV, Kritchavsky D.: Plant and marine sterols and cholesterol metabolism. ln Spiller GA, ed. Nutritional Pharmacology. New York, NY:
Alan R Liss Inc; 1981 pp. 31—72 Alan R Liss Inc; 1981 pp. 31-72
6) Vahoyny GV, Kiitchevsky D.: Plant and marine sterols and cholesterol metabolism. ln Spiller GA, ed. Nutritional Pharmacology. New York NY: 6) Vahoyny GV, Kiitchevsky D.: Plant and marine sterols and cholesterol metabolism. ln Spiller GA, ed. Nutritional Pharmacology. New York NY:
Alan R Liss Inc: 1981 pp. 31—72 Alan R Liss Inc: 1981 pp. 31-72
7) Tilvis RS, Miettinen TA: Am J Clin Nutr.: 43; 92—97, 1986 7) Tilvis RS, Miettinen TA: Am J Clin Nutr.: 43; 92—97, 1986
8) Martson FH; Grundy SM, Crouse JR: Am J Clin Nutr. 35, 697-700, 1982 9) Steinegger E & Hånsel R: Pharmakognosie, 5. Aufl., Springer-Lehrbuch, 8) Martson FH; Grundy SM, Crouse JR: Am J Clin Nutr. 35, 697-700, 1982 9) Steinegger E & Hånsel R: Pharmacognosie, 5. Aufl., Springer-Lehrbuch,
Berlin-Haidelberg-New York, 1992, p. 195 Berlin-Heidelberg-New York, 1992, p. 195
10) Hånsel R & Haas H.: Therapie mit Phutopharmaka, Springer-Verlag, Berlin-Heidelberg-New York-Tokyo, 1983 pp. 187-188 11) - Hånsel R: Phutopharmaka, Grundlagen und Praxis, 2. Auflage, Springer-Veriag, Berlin-Heidelberg-New York, 1991 pp. 192—193 12) Jones PJH et al. : Canadian Journal of Physiology & Pharmacology 75(3): 217-227, 1997 10) Hånsel R & Haas H.: Therapie mit Phutopharmaka, Springer-Verlag, Berlin-Heidelberg-New York-Tokyo, 1983 pp. 187-188 11) - Hånsel R: Phutopharmaka, Grundlagen und Praxis, 2. Auflage, Springer- Veriag, Berlin-Heidelberg-New York, 1991 pp. 192-193 12) Jones PJH et al. : Canadian Journal of Physiology & Pharmacology 75(3): 217-227, 1997
13) Field, FJ et al. : Journal of Lipid Research. 38(2): 348—360, 1997 13) Field, FJ et al. : Journal of Lipid Research. 38(2): 348—360, 1997
14) Richter W et al. : Current Research. 57(7): 497—505, 1996 14) Richter W et al. : Current Research. 57(7): 497—505, 1996
15) Mattson FH et al. : American Journal of Clinical Nutrition. 35(4): 697—700, 1982 16) Uchita E et al. : Japanese Journal of Pharmacology. 33(1): 103—12, 1983 17) Vahouny GB et al. : American Journal of Clinical Nutricion. 37(5): 805—9. 1983 15) Mattson FH et al. : American Journal of Clinical Nutrition. 35(4): 697-700, 1982 16) Uchita E et al. : Japanese Journal of Pharmacology. 33(1): 103-12, 1983 17) Vahouny GB et al. : American Journal of Clinical Nutrition. 37(5): 805—9. 1983
Claims (13)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI980450A FI109327B (en) | 1998-02-27 | 1998-02-27 | Process for the preparation of a fat-like mixture of beta-sitosterol which lowers total serum and LDL cholesterol levels |
PCT/FI1999/000121 WO1999043218A1 (en) | 1998-02-27 | 1999-02-15 | Method for producing a fat mixture |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20004269L NO20004269L (en) | 2000-08-25 |
NO20004269D0 NO20004269D0 (en) | 2000-08-25 |
NO316619B1 true NO316619B1 (en) | 2004-03-08 |
Family
ID=8551051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20004269A NO316619B1 (en) | 1998-02-27 | 2000-08-25 | Fat blend containing ß-sitosterol or ß-sitosterol and ß-sitostanol, a process for producing such a fat blend, using the same and a process for administering ß-sitosterol or ß-sitosterol and ß-sitostanol to lower serum tot |
Country Status (24)
Country | Link |
---|---|
US (1) | US6531463B1 (en) |
EP (1) | EP1065945B1 (en) |
JP (1) | JP3574812B2 (en) |
KR (1) | KR100447450B1 (en) |
CN (1) | CN1118248C (en) |
AU (1) | AU751879B2 (en) |
BR (1) | BR9908414A (en) |
CA (1) | CA2322173C (en) |
CZ (1) | CZ300175B6 (en) |
DE (1) | DE69934878T2 (en) |
DK (1) | DK1065945T3 (en) |
EE (1) | EE05189B1 (en) |
ES (1) | ES2277426T3 (en) |
FI (1) | FI109327B (en) |
HK (1) | HK1036199A1 (en) |
HU (1) | HUP0102291A3 (en) |
ID (1) | ID26998A (en) |
IS (1) | IS2460B (en) |
NO (1) | NO316619B1 (en) |
NZ (1) | NZ506467A (en) |
PL (1) | PL192088B1 (en) |
PT (1) | PT1065945E (en) |
RU (1) | RU2198531C2 (en) |
WO (1) | WO1999043218A1 (en) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI109327B (en) * | 1998-02-27 | 2002-07-15 | Spice Sciences Oy | Process for the preparation of a fat-like mixture of beta-sitosterol which lowers total serum and LDL cholesterol levels |
SE512958C2 (en) * | 1998-04-30 | 2000-06-12 | Triple Crown Ab | Cholesterol-lowering composition containing beta-sitosterol and / or beta-sitostanol and process for its preparation |
BR9910950A (en) * | 1998-06-05 | 2002-02-13 | Forbes Medi Tech Inc | Compositions comprising phytosterol and phytostanol having increased solubility and dispersibility |
US5892068A (en) * | 1998-08-25 | 1999-04-06 | Mcneil-Ppc, Inc. | Preparation of sterol and stanol-esters |
NZ333817A (en) | 1998-08-25 | 2000-09-29 | Mcneil Ppc Inc | Process for preparing stanol/sterol fatty acid esters such as beta sitosterol fatty acid esters, useful in reducing cholesterol levels |
US6410758B2 (en) | 1999-05-24 | 2002-06-25 | Mcneil-Ppc, Inc. | Preparation of sterol and stanol-esters |
ATE286660T1 (en) * | 1999-11-03 | 2005-01-15 | Forbes Medi Tech Inc | COMPOSITIONS CONTAINING EDIBLE OILS OR FATS AND PHYTOSTEROLS AND/OR PHYTOSTANOLS DISSOLVED THEREIN |
US6677327B1 (en) | 1999-11-24 | 2004-01-13 | Archer-Daniels-Midland Company | Phytosterol and phytostanol compositions |
ES2331724T3 (en) | 2000-04-14 | 2010-01-14 | Mars, Incorporated | COMPOSITIONS AND METHODS TO IMPROVE VASCULAR HEALTH. |
FI20010780A0 (en) * | 2001-04-12 | 2001-04-12 | Raisio Benecol Oy | Improved compositions |
GB0114014D0 (en) * | 2001-06-08 | 2001-08-01 | Novartis Nutrition Ag | Compostion and use |
GB0118225D0 (en) * | 2001-07-26 | 2001-09-19 | Nestle Sa | Milk product comprising unesterfied sterol |
WO2003043433A1 (en) * | 2001-11-16 | 2003-05-30 | Brandeis University | Prepared foods containing triglyceride-recrystallized non-esterified phytosterols |
US7144595B2 (en) | 2001-11-16 | 2006-12-05 | Brandeis University | Prepared foods containing triglyceride-recrystallized non-esterified phytosterols |
US7678405B2 (en) | 2001-12-07 | 2010-03-16 | Ajinomoto Co., Inc. | Oil-in-water type emulsion comprising vegetable sterols |
FI117082B (en) * | 2002-02-08 | 2006-06-15 | Raisio Yhtymae Oyj | Pasta product containing esterified plant sterols |
CA2434887A1 (en) * | 2003-03-07 | 2004-09-07 | Standard Foods Corporation | Flour composition containing non-wheat cereal components, and noodles produced therefrom |
MXPA06001003A (en) * | 2003-07-29 | 2006-04-11 | Unilever Nv | Food product comprising phytosterols. |
US8158184B2 (en) * | 2004-03-08 | 2012-04-17 | Bunge Oils, Inc. | Structured lipid containing compositions and methods with health and nutrition promoting characteristics |
US20050281932A1 (en) * | 2004-06-18 | 2005-12-22 | Good Humor - Breyers Ice Cream | Frozen confection |
PL1688044T3 (en) * | 2005-02-08 | 2012-07-31 | Dragsbaek As | A butter-like dairy spread and method for production |
HUP0500582A1 (en) * | 2005-06-13 | 2007-08-28 | Csaba Jozsef Dr Jaszberenyi | Foods food-additives and nutriment supplements or feed-additives with synergetic physiological effect |
US7575768B2 (en) * | 2005-09-07 | 2009-08-18 | Brandeis University | Dietary supplements and prepared foods containing triglyceride-recrystallized non-esterified phytosterols |
US20070087085A1 (en) * | 2005-10-17 | 2007-04-19 | Bunge Oils, Inc. | Protein-containing food product and coating for a food product and method of making same |
US20080113067A1 (en) * | 2005-10-17 | 2008-05-15 | Monoj Sarma | Protein-Containing Food Product and Coating for a Food Product and Method of Making Same |
US20070148311A1 (en) * | 2005-12-22 | 2007-06-28 | Bunge Oils, Inc. | Phytosterol esterification product and method of make same |
US7790495B2 (en) * | 2007-10-26 | 2010-09-07 | International Business Machines Corporation | Optoelectronic device with germanium photodetector |
US20110223312A1 (en) * | 2009-11-30 | 2011-09-15 | Daniel Perlman | Triglyceride-encapsulated phytosterol microparticles dispersed in beverages |
CA2811804C (en) | 2010-09-22 | 2018-10-02 | Unilever Plc | Edible fat continuous spreads |
EP2692238A1 (en) * | 2012-08-03 | 2014-02-05 | Bunge Növényolajipari Zártköruen Muködo Részvénytársasag | New fat blend composition |
WO2014207805A1 (en) | 2013-06-24 | 2014-12-31 | もったいないバイオマス株式会社 | Natural binding auxiliary material, derived from lipophilic pith fibers (ground inner stem fibers) separated from sunflower stems, for processed foods, and processed food containing same |
CN103734743A (en) * | 2014-01-25 | 2014-04-23 | 郑鉴忠 | Food for adsorbing phytosterol and making method thereof |
EP3403508A1 (en) | 2017-05-18 | 2018-11-21 | DMK Deutsches Milchkontor GmbH | Dairy spread composition, its production method and use of the composition |
RU2770212C1 (en) * | 2021-09-14 | 2022-04-14 | Федеральное государственное бюджетное научное учреждение "Северо-Кавказский федеральный научный центр садоводства, виноградарства, виноделия" | Method for producing bun for school meal |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3085939A (en) * | 1959-05-11 | 1963-04-16 | Upjohn Co | Oil-in-water emulsion for oral administration, and process for preparation |
US3751569A (en) | 1972-01-12 | 1973-08-07 | Procter & Gamble | Clear cooking and salad oils having hypocholesterolemic properties |
US3865939A (en) * | 1973-02-23 | 1975-02-11 | Procter & Gamble | Edible oils having hypocholesterolemic properties |
JPS57206336A (en) | 1981-06-12 | 1982-12-17 | Ajinomoto Co Inc | Edible oil |
JPH0659164B2 (en) * | 1985-12-23 | 1994-08-10 | 理研ビタミン株式会社 | Sterin-containing composition |
CA2102112C (en) | 1991-05-03 | 2010-04-13 | Tatu Miettinen | A substance for lowering high cholesterol level in serum and a method for preparing the same |
ES2235233T3 (en) * | 1996-05-10 | 2005-07-01 | Unilever N.V. | COMPOSITION CONTAINING A LIQUID FAT COMPONENT. |
US6423363B1 (en) * | 1997-08-22 | 2002-07-23 | Lipton, Division Of Conopco, Inc. | Aqueous dispersion |
FI109327B (en) * | 1998-02-27 | 2002-07-15 | Spice Sciences Oy | Process for the preparation of a fat-like mixture of beta-sitosterol which lowers total serum and LDL cholesterol levels |
-
1998
- 1998-02-27 FI FI980450A patent/FI109327B/en not_active IP Right Cessation
-
1999
- 1999-02-15 DK DK99903716T patent/DK1065945T3/en active
- 1999-02-15 DE DE69934878T patent/DE69934878T2/en not_active Expired - Lifetime
- 1999-02-15 US US09/622,579 patent/US6531463B1/en not_active Expired - Fee Related
- 1999-02-15 PT PT99903716T patent/PT1065945E/en unknown
- 1999-02-15 BR BR9908414-7A patent/BR9908414A/en not_active Application Discontinuation
- 1999-02-15 CA CA002322173A patent/CA2322173C/en not_active Expired - Fee Related
- 1999-02-15 CN CN99804189A patent/CN1118248C/en not_active Expired - Fee Related
- 1999-02-15 CZ CZ20003122A patent/CZ300175B6/en not_active IP Right Cessation
- 1999-02-15 AU AU24276/99A patent/AU751879B2/en not_active Ceased
- 1999-02-15 JP JP2000533026A patent/JP3574812B2/en not_active Expired - Fee Related
- 1999-02-15 WO PCT/FI1999/000121 patent/WO1999043218A1/en active IP Right Grant
- 1999-02-15 EP EP99903716A patent/EP1065945B1/en not_active Expired - Lifetime
- 1999-02-15 RU RU2000124522/13A patent/RU2198531C2/en not_active IP Right Cessation
- 1999-02-15 HU HU0102291A patent/HUP0102291A3/en unknown
- 1999-02-15 PL PL342512A patent/PL192088B1/en not_active IP Right Cessation
- 1999-02-15 EE EEP200000498A patent/EE05189B1/en not_active IP Right Cessation
- 1999-02-15 NZ NZ506467A patent/NZ506467A/en unknown
- 1999-02-15 ES ES99903716T patent/ES2277426T3/en not_active Expired - Lifetime
- 1999-02-15 ID IDW20001745A patent/ID26998A/en unknown
- 1999-02-15 KR KR10-2000-7009572A patent/KR100447450B1/en not_active IP Right Cessation
-
2000
- 2000-08-22 IS IS5596A patent/IS2460B/en unknown
- 2000-08-25 NO NO20004269A patent/NO316619B1/en not_active IP Right Cessation
-
2001
- 2001-09-28 HK HK01106863A patent/HK1036199A1/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU751879B2 (en) | Method for producing a fat mixture | |
JP5636398B2 (en) | Oil composition | |
US20030099747A1 (en) | Thickened oil compositions of edible oil | |
US6878394B2 (en) | Egg replacer concentrate and liquid egg replacer | |
US11672265B2 (en) | Egg replacement containing euglena-derived components | |
KR20040036941A (en) | Oil composition | |
US20020132035A1 (en) | Synthetic fat composition | |
RU2335146C1 (en) | Food fatty composition for functional feeding and method of production thereof | |
JP2015128406A (en) | Butter alternative fat | |
JPWO2018012262A1 (en) | Metabolic syndrome inhibitor | |
JP2012191929A (en) | Edible cream | |
JP2002165559A (en) | Processed oil and fat for food and food utilizing the same | |
MXPA00008356A (en) | Method for producing a fat mixture | |
WO2004068956A1 (en) | Kit for preparing food product | |
JP7150397B2 (en) | Oil and fat composition for white sauce | |
JP2018153122A (en) | Oil-in-water-type emulsified oil and fat for sponge dough |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |